Abstract
Background
Narcolepsy is an uncommon neurological disorder characterised by irresistible spells of sleep associated with abnormal rapid eye movement (REM) sleep. The association between narcolepsy and human leukocyte antigen HLA- DQB1*06:02 has been established elsewhere but remains to be investigated among Saudi Arabian patients with narcolepsy.
Methods
A total of 29 Saudi patients with type I or type 2 narcolepsy comprising of 23 (79%) males and 6 (21%) females with a mean age of 17.2 ± 9.6 years were included in this study. Type 1 or type 2 narcolepsy was diagnosed by full polysomnography followed by a multiple sleep latency test in accordance with International Classifications of Sleep Disorders-3 criteria. HLA typing for DQB1 alleles was performed by polymerase chain reaction and hybridization with sequence-specific oligonucleotide probes. Differences in clinical and sleep parameters were compared by univariable analyses. HLA-DQB1*06:02 frequency was systematically compared with the published literature.
Results
Type 1 narcolepsy was diagnosed in 19/29 (65.5%) patients, whereas 10/29 (34.5%) patients had type 2 narcolepsy. DQB1*06:02 was present in 25/29 (86.2%) patients; 15/19 (78.9%) narcolepsy type 1 patients and 10/10 (100%) narcolepsy type 2 patients harboured the DQB1*06:02 allele. REM latency was significantly lower in DQB1*06:02-positive patients compared to DQB1*06:02-negative patients (17.6 ± 32.3 min vs. 106.0 ± 86.0 min; p = 0.025). Epworth Sleepiness Scale scores were significantly higher among type 1 than type 2 narcolepsy patients (19.7 ± 3.2 vs 15.3 ± 3.6; p = 0.02).
Conclusions
DQB1*06:02 allele frequencies among Saudi patients with narcolepsy were consistent with previously published data.
Similar content being viewed by others
References
Chabas D, Taheri S, Renier C, Mignot E (2003) The genetics of narcolepsy. Annu Rev Genomics Hum Genet 4:459–483
Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G (2007) The epidemiology of narcolepsy. Sleep 30(1):13–26
Kryger MH, Walid R, Manfreda J (2002) Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep 25(1):36–41
Bahammam AS, Alenezi AM (2006) Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder. Neurosciences (Riyadh) 11(4):302–307
Mignot E (1998) Genetic and familial aspects of narcolepsy. Neurology 50(2 Suppl 1):S16–S22
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355(9197):39–40
Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6(9):991–997
Juji T, Satake M, Honda Y, Doi Y (1984) HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24(5):316–319
Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C (1997) HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20(11):1012–1020
Mignot E, Lin X, Hesla PE, Dement WC, Guilleminault C, Grumet FC (1993) A novel HLA DR17,DQ1 (DQA1-0102/DQB1-0602 positive) haplotype predisposing to narcolepsy in Caucasians. Sleep 16(8):764–765
Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, Lecendreux M, Lammers GJ, Donjacour CE, Du Pasquier RA, Pfister C, Petit B, Hor H, Muhlethaler M, Tafti M (2010) Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 120(3):713–719
Kawashima M, Lin L, Tanaka S, Jennum P, Knudsen S, Nevsimalova S, Plazzi G, Mignot E (2010) Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 33(7):869–874
Lim AS, Scammell TE (2010) The trouble with tribbles: do antibodies against TRIB2 cause narcolepsy? Sleep 33(7):857–858
Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M (2010) Anti-tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 33(7):875–878
AASM (2014) American Academy of Sleep Medicine (AASM). International classification of sleep disorders (ICSD), 3rd ed. Darien, IL: AASM
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
Bahammam AS, Almushailhi K, Pandi-Perumal SR, Sharif MM (2014) Intermittent fasting during Ramadan: does it affect sleep? J Sleep Res 23(1):35–43
Qasrawi SQ, Albarrak AM, Alharbi AS, Nashwan S, Almeneessier AS, Pandi-Perumal SR, Alsaadi MM, BaHammam AS (2017) Narcolepsy in Saudi patients before and after the 2009 H1N1 vaccination. The experience of 2 referral centers. Saudi Med J 38(12):1196–1200
EEG arousals: scoring rules and examples (1992) A preliminary report from the sleep disorders atlas task force of the American sleep disorders association. Sleep 15(2):173–184
Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, Troester MT, Vaughn BV (2017) AASM scoring manual updates for 2017 (version 2.4). J Clin Sleep Med 13(5):665–666
Alaez C, Lin L, Flores AH, Vazquez M, Munguia A, Mignot E, Haro R, Baker H, Gorodezky C (2008) Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Medical Genetics 9:79
Chen YH, Huang YS, Chien WH, Chen CH (2013) Association analysis of the major histocompatibility complex, class II, DQ beta1 gene, HLA-DQB1, with narcolepsy in Han Chinese patients from Taiwan. Sleep Med 14(12):1393–1397
Coelho FM, Pradella-Hallinan M, Pedrazzoli M, Soares CA, Fernandes GB, Goncalves AL, Tufik S, Bittencourt LR (2010) Traditional biomarkers in narcolepsy: experience of a Brazilian sleep Centre. Arq Neuropsiquiatr 68(5):712–715
Dolenc-Grosel L, Vodusek DB (2002) The importance of HLA DQB1*0602 typing in Slovene patients with narcolepsy. Cellular Molecular Biology Letters 7(2):359–360
Geremew D, Rahimi-Golkhandan A, Sadeghniiat-Haghighi K, Shakiba Y, Khajeh-Mehrizi A, Ansaripour B, Izad M (2017) Association study of HLA-DQB1*0602 allele in Iranian patients with narcolepsy. Iranian J Allergy, Asthma, Immunology 16(5):452–456
Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E (2014) HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 37(10):1601–1608
Hong SC, Leen K, Park SA, Han JH, Lee SP, Lin L, Okun M, Nishino S, Mignot E (2002) HLA and hypocretin studies in Korean patients with narcolepsy. Sleep 25(4):440–444
Hong SC, Lin L, Lo B, Jeong JH, Shin YK, Kim SY, Kweon Y, Zhang J, Einen M, Smith A, Hansen J, Grumet FC, Mignot E (2007) DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol 68(1):59–68
Miyagawa T, Toyoda H, Hirataka A, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Imai M, Fujimura Y, Tamura Y, Ikegami A, Wada Y, Moriya S, Furuya H, Kato M, Omata N, Kojima H, Kashiwase K, Saji H, Khor SS, Yamasaki M, Wada Y, Ishigooka J, Kuroda K, Kume K, Chiba S, Yamada N, Okawa M, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K (2015) New susceptibility variants to narcolepsy identified in HLA class II region. Hum Mol Genet 24(3):891–898
Pelin Z, Guilleminault C, Risch N, Grumet FC, Mignot E (1998) HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in narcolepsy multicenter study group. Tissue Antigens 51(1):96–100
Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E (1997) HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 48(6):1550–1556
Vrana M, Siffnerova V, Pecherkova P, Ratajova E, Sonka K (2016) Distribution of HLA-DQB1 in Czech patients with central Hypersomnias. Arch Immunol Ther Exp 64(Suppl 1):89–98
Wing YK, Chen L, Fong SY, Ng MH, Ho CK, Cheng SH, Tang NL, Li AM (2008) Narcolepsy in southern Chinese patients: clinical characteristics, HLA typing and seasonality of birth. J Neurol Neurosurg Psychiatry 79(11):1262–1267
Han F, Lin L, Li J, Aran A, Dong SX, An P, Zhao L, Li M, Li QY, Yan H, Wang JS, Gao HY, Gao ZC, Strohl KP, Mignot E (2011) Presentations of primary hypersomnia in Chinese children. Sleep 34(5):627–632
Bruck D, Costa A (2003) The natural history of health and symptoms in narcolepsy: a 10 year longitudinal study. Australian J Primary Health 9:59–67
Hong SC, Hayduk R, Lim J, Mignot E (2000) Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial. Sleep Med 1(1):33–39
Mignot E, Young T, Lin L, Finn L (1999) Nocturnal sleep and daytime sleepiness in normal subjects with HLA-DQB1*0602. Sleep 22(3):347–352
Watson NF, Ton TG, Koepsell TD, Gersuk VH, Longstreth WT Jr (2010) Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep 33(1):29–35
Harsh J, Peszka J, Hartwig G, Mitler M (2000) Night-time sleep and daytime sleepiness in narcolepsy. J Sleep Res 9(3):309–316
Jeong JH, Hong SC, Shin YK, Han JH, Lee SP (2007) HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy. J Korean Med Sci 22(1):127–131
Coelho FM, Pradella-Hallinan M, Predazzoli Neto M, Bittencourt LR, Tufik S (2009) Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in Sao Paulo. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 31(1):10–14
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al Shareef, S.M., AlAnbay, E., AlKhathlan, M.A. et al. HLA-DQB1*06:02 allele frequency and clinic-polysomnographic features in Saudi Arabian patients with narcolepsy. Sleep Breath 23, 303–309 (2019). https://doi.org/10.1007/s11325-018-1717-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-018-1717-4